Prostate cancer prevention and screening: an ASCO update

Your editor was unable to attend the session on prostate cancer prevention and screening at the recent annual meeting of the American Society for Clinical Oncology (ASCO) because he is still working on how to be in two places at once. … READ MORE …

AUA report and update no. 5: Monday, April 27, 2009

So Dr Gerry Andriole just completed his presentation of the main results of the REDUCE trial, designed to test the ability of dutasteride (Avodart) to prevent prostate cancer in men believed to be at high risk for this disease — and the results are positive. … READ MORE …